[ad_1]
“We are taking a break from vaccination with AstraZeneca in Norway,” Jeir Bukholm, director of infection prevention and control at the National Institutes of Health, told reporters.
“We are waiting for more information to make sure there is a link between this vaccine and blood clots. [susidarymo] case, “he added.
Earlier on Thursday, Danish health services announced a temporary suspension of AstraZeneca, which caused blood clots in some patients after the drug was injected.
The decision to stop vaccination with this drug was made “after reports of serious blood clots [susidarymo] cases of people vaccinated with AstraZeneca COVID-19 ”, according to a report from the Danish Board of Health.
However, the service cautiously added that “there is currently no evidence of a link between the vaccine and blood clots.”
Anxiety about the effect of the drug.
Austria announced on Monday that it would discontinue vaccines with a batch of AstraZeneca vaccines after a 49-year-old nurse had a “significant increase in blood clotting” a few days after injecting COVID-19.
Four other EU countries – Estonia, Latvia, Lithuania and Luxembourg – have also announced the cessation of vaccination with this batch, which produced a total of 1 million. doses distributed in 17 European countries.
However, Denmark is suspending the use of all its AstraZeneca vaccine stocks.
The European Medicines Agency (EMA) said on Wednesday, according to a preliminary study, that the batch of AstraZeneca vaccine in question is unlikely to be linked to the death of a nurse in Austria.
According to the EEA, as of March 9, 22 cases of blood clots had been reported in the European Economic Area (EEA).
“It is important to emphasize that we have not stopped using the AstraZeneca vaccine, we have just stopped using it,” said Sioren Brostriomo, director of the Danish Board of Health.
Denmark reported that one of the people vaccinated with the drug had died. The EEA has launched an investigation into this case.
“There is extensive documentation available to show that the vaccine is safe and effective. However, both we and the Danish Medicines Agency must act on the basis of information about possible serious side effects, both in Denmark and in other European countries.” Brostrom said.
The decision to stop vaccination with this vaccine will be re-evaluated after two weeks. This measure is likely to slow down the vaccination campaign in Denmark.
Copenhagen currently expects all adults in the country to be vaccinated by mid-August, the health board said. It was previously predicted that this would be done in early July.
It is not allowed to publish, quote or reproduce the information of the BNS news agency in the media and on websites without the written consent of the UAB “BNS”.
[ad_2]
